Chest Medicine
Airborne transmission of SARS-CoV-2: theoretical considerations and available evidence
14 Jul, 2020 | 08:30h | UTCAirborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence – JAMA
Author Interview: How Is COVID-19 Transmitted?
Related: The debate over “airborne” coronavirus spread, explained – Vox
Perspective – “My patient caught Covid-19 twice. So long to herd immunity hopes”
14 Jul, 2020 | 08:19h | UTCMy patient caught Covid-19 twice. So long to herd immunity hopes. – Vox
Review: Pathophysiology, Transmission, Diagnosis, and Treatment of COVID-19
13 Jul, 2020 | 00:29h | UTC
Meta: analysis: Interferon-γ release assays vs. tuberculin skin test for detection and management of latent tuberculosis infection
14 Jul, 2020 | 08:14h | UTC
Review: Extrapulmonary Manifestations of COVID-19
13 Jul, 2020 | 00:28h | UTCExtrapulmonary manifestations of COVID-19 – Nature Medicine
Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology
WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice on Masks Still Falls Short
13 Jul, 2020 | 00:22h | UTCRelated: Transmission of SARS-CoV-2: implications for infection prevention precautions – World Health Organization AND It is Time to Address Airborne Transmission of COVID-19 – Clinical Infectious Diseases
Comprehensive Review: Face Masks and Coverings for the General Public
13 Jul, 2020 | 00:20h | UTCCommentary: Oxford COVID-19 study: face masks and coverings work – act now – University of Oxford
Editorial – Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
13 Jul, 2020 | 00:18h | UTCRelated Editorial: COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution – One Health
Updated Systematic Review: Convalescent Plasma or Hyperimmune Immunoglobulin for COVID‐19
13 Jul, 2020 | 00:13h | UTCCommentary: Convalescent plasma to treat people with COVID-19: the evidence so far – Evidently Cochrane
Related Commentary on Twitter
https://twitter.com/CochraneUK/status/1281613914296516608
Case Reports: 2 Adults with Kawasaki-like Multisystem Inflammatory Syndrome Associated with COVID-19
13 Jul, 2020 | 00:05h | UTCCase Report 1: An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 – The Lancet
Case Report 2: An adult presentation consistent with PIMS-TS – The Lancet Rheumatology
Related Commentary on Twitter
First reports of Kawasaki-like #SARSCoV2 multi-system inflammatory syndrome in adultshttps://t.co/FYNWlxdk9q @TheLancet https://t.co/lnHMUxA7Ux @TheLancetRheum
21 yo in London, 45 yo in New York City pic.twitter.com/lLmSRzBjs4— Eric Topol (@EricTopol) July 11, 2020
Comparative Assessment of Particle Removal Efficiency of Fabric Masks as Alternatives to Standard Surgical Masks for PPE
13 Jul, 2020 | 00:07h | UTC
Related Commentary on Twitter
New @CellPressNews: Quantifying the performance of the different masks 😷 (N95, surgical, cloth)
Importance of fit and nylon overlayhttps://t.co/ZoSguWbm0X pic.twitter.com/3OAmlfRFIu— Eric Topol (@EricTopol) July 9, 2020
Observational Analysis: BCG Vaccine and COVID-19
13 Jul, 2020 | 00:02h | UTCCommentaries: Expert reaction to study looking at BCG vaccination programmes and COVID-19 deaths in different countries – Science Media Centre AND Preliminary study suggests tuberculosis vaccine may be limiting COVID-19 deaths – Virginia Tech
Persistent Symptoms in Patients After Acute COVID-19
10 Jul, 2020 | 09:46h | UTCPersistent Symptoms in Patients After Acute COVID-19 – JAMA
Related Commentary on Twitter
Just out: new study from @JAMA_current: of 143 patients discharged from hospital with #COVID19 (average age 56), only 13% were symptom-free an average of 2 months later. Fatigue, trouble breathing, joint pain, chest pain in >20%. https://t.co/KKwfpHnQHJ pic.twitter.com/QKRNBLeaGq
— Dr. Tom Frieden (@DrTomFrieden) July 9, 2020
Systematic Review: Signs and Symptoms to Determine if a Patient Presenting in Primary care or Hospital Outpatient Settings has COVID‐19
10 Jul, 2020 | 09:45h | UTCCommentary: Signs and symptoms of COVID-19: new Cochrane evidence – Evidently Cochrane
WHO Scientific Brief: Transmission of SARS-CoV-2: Implications for Infection Prevention Precautions
10 Jul, 2020 | 09:26h | UTCQ&A: How is COVID-19 transmitted?
Commentaries: WHO: Aerosolized Particles Unlikely To Be Significant Source Of COVID-19 Transmission – NPR AND The Coronavirus Can Be Airborne Indoors, W.H.O. Says – The New York Times
The Laboratory Diagnosis of COVID-19– Frequently-Asked Questions
10 Jul, 2020 | 09:23h | UTCThe Laboratory Diagnosis of COVID-19– Frequently-Asked Questions – Clinical Infectious Diseases
OpenSAFELY: Factors Associated with COVID-19 Death in 17 Million Patients
9 Jul, 2020 | 09:33h | UTCOpenSAFELY: factors associated with COVID-19 death in 17 million patients – Nature
Commentaries: Study of 17 Million Identifies Crucial Risk Factors for Coronavirus Deaths – The New York Times AND Expert reaction to paper from OpenSAFELY platform quantifying clinical and demographic risk factors for COVID19-related death – Science Media Centre
Related Commentary on Twitter
New @nature: the risk factors for dying from #COVID19 from >17 million people and ~11,000 deaths https://t.co/VnEs9sC2Sn @bengoldacre and colleagues
importance of age, sex, race, diabetes, obesity, many other conditions
not risk factor: hypertension; current smoker protective pic.twitter.com/xuZeHUUDXq— Eric Topol (@EricTopol) July 8, 2020
Podcast: Acute Lung Injury in Covid-19
9 Jul, 2020 | 09:28h | UTCAudio Interview: Acute Lung Injury in Covid-19 – New England Journal of Medicine
[Abstract Only] Randomized Trial: Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts
9 Jul, 2020 | 09:22h | UTCCommentary: Baloxavir Helps Prevent Flu in Exposed Household Contacts – NEJM Journal Watch
COVID-19-associated Acute Respiratory Distress Syndrome: Is A Different Approach to Management Warranted?
8 Jul, 2020 | 01:02h | UTC
Meta-Analysis: Standardized Management for Hypoxemic Respiratory Failure and ARDS
8 Jul, 2020 | 01:01h | UTC
Methotrexate is Not an Additional Risk Factor for Interstitial Lung Disease in RA Patients
8 Jul, 2020 | 00:54h | UTCRelated Review: Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows – Journal of Clinical Medicine
New USPSTF Draft Statement Now Recommends Lung Cancer Screening Beginning at Age 50 Among People at High Risk
8 Jul, 2020 | 00:56h | UTCDraft Recommendation Statement: Lung Cancer Screening – U.S Preventive Services Task Force
Commentaries: Proposed changes to lung cancer screening guidance could increase scans among Black patients, women – STAT
It is Time to Address Airborne Transmission of COVID-19
7 Jul, 2020 | 09:04h | UTCIt is Time to Address Airborne Transmission of COVID-19 – Clinical Infectious Diseases
Commentaries: Global experts: Ignoring airborne COVID spread risky – CIDRAP AND Coronavirus can float in air and WHO and CDC should tell people that, experts say – CNN AND Expert reaction to commentary about potential airborne transmission of the SARS-CoV-2 virus – Science Media Centre
Clinical Practice Guideline: Treatment of Nontuberculous Mycobacterial Pulmonary Disease
7 Jul, 2020 | 08:53h | UTC